Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX
· Real-Time Price · USD
0.80
0.00 (0.13%)
At close: Aug 15, 2025, 3:59 PM
0.82
2.44%
After-hours: Aug 15, 2025, 04:00 PM EDT
Lexaria Bioscience Income Statement
Financials in USD. Fiscal
year is
September - August.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | Nov 30, 2020 |
Revenue | 615.92K | 525.92K | 496.92K | 464.28K | 376.85K | 386K | 261.02K | 211.22K | 325.8K | 332.37K | 342.99K | 255.4K | 175.27K | 279.61K | 440.96K | 722.74K | 825.46K | 702.82K | 618.12K |
Cost of Revenue | 2.72K | 2.72K | 18.65K | 20.75K | 24.19K | 36.93K | 23.96K | 34.93K | 72.75K | 78.64K | 82.07K | 71.84K | 50.9K | 92.25K | 116.44K | 175.35K | 168.14K | 128.47K | 156K |
Gross Profit | 613.2K | 523.2K | 478.27K | 443.52K | 352.66K | 349.06K | 237.06K | 176.28K | 253.05K | 253.73K | 260.93K | 183.56K | 124.37K | 187.35K | 324.52K | 547.39K | 657.32K | 574.36K | 462.11K |
Operating Income | -11.4M | -9.39M | -7.3M | -5.75M | -4.62M | -5.26M | -5.92M | -6.55M | -6.99M | -7.02M | -7.15M | -7.37M | -7.29M | -7.37M | -8.41M | -7.14M | -6.49M | -5.32M | -3.83M |
Interest Income | 7.19K | 7K | 7K | 14.31K | 50.51K | 65.95K | 80.94K | 77.36K | 34.17K | 18.73K | 3.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -11.39M | -9.39M | -7.33M | -5.81M | -4.87M | -5.47M | -6.13M | -6.71M | -6.98M | -7.01M | -7.15M | -7.38M | -7.17M | -7.32M | -5.45M | -4.16M | -3.63M | -2.46M | -3.87M |
Net Income | -11.39M | -9.38M | -7.32M | -5.8M | -4.85M | -5.44M | -6.09M | -6.66M | -6.89M | -6.9M | -7.03M | -7.27M | -6.98M | -7.15M | -5.32M | -4.03M | -3.56M | -2.37M | -3.72M |
Selling & General & Admin | 4.68M | 4.73M | 4.04M | 3.84M | 3.08M | 2.65M | 2.75M | 3.06M | 3.72M | 4.64M | 5.2M | 5.72M | 5.58M | 5.99M | 5.79M | 4.97M | 4.68M | 3.87M | 3.71M |
Research & Development | 7.32M | 5.18M | 3.74M | 2.36M | 1.89M | 2.96M | 3.41M | 3.67M | 3.52M | 2.63M | 2.21M | 1.84M | 1.93M | 1.63M | 1.53M | 1.26M | 891.6K | 461.71K | 471.87K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -83.79K | -55.86K | -27.93K | n/a | 112.66K | 112.81K | 113.17K |
Operating Expenses | 12.01M | 9.91M | 7.78M | 6.2M | 4.98M | 5.61M | 6.16M | 6.73M | 7.24M | 7.28M | 7.41M | 7.57M | 7.42M | 7.57M | 7.29M | 6.23M | 5.69M | 4.44M | 4.29M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | -15.93K | -15.93K | -15.93K | -15.93K | n/a | n/a | n/a | n/a | n/a | n/a | -410.27K | -84.77K | -27.91K | n/a | 485.05K | 208.06K | 185.91K |
Cost & Expenses | 8.09M | 9.91M | 7.8M | 6.22M | 5M | 5.65M | 6.18M | 6.76M | 7.32M | 7.36M | 7.49M | 7.64M | 7.47M | 7.66M | 7.41M | 6.41M | 5.86M | 4.57M | 4.45M |
Income Tax Expense | 3.76K | 3.76K | -3.19K | -3.19K | -12.89K | -24.95K | -21.76K | -35.12K | -25.42K | -13.36K | -13.36K | n/a | -250.87K | -190.56K | -3.09M | -3.12M | -2.86M | -2.9M | -49.34K |
Shares Outstanding (Basic) | 18.3M | 17.51M | 16.67M | 13.12M | 13.86M | 10.77M | 9.05M | 6.61M | 6.44M | 5.95M | 5.95M | 5.89M | 5.95M | 5.91M | 5.73M | 5.1M | 5.1M | 4.05M | 3M |
Shares Outstanding (Diluted) | 18.3M | 17.51M | 16.67M | 13.12M | 13.86M | 10.77M | 9.05M | 6.61M | 6.44M | 5.95M | 5.95M | 5.89M | 5.95M | 5.91M | 5.73M | 5.1M | 5.1M | 4.05M | 3M |
EPS (Basic) | -0.69 | -0.61 | -0.52 | -0.49 | -0.51 | -0.75 | -0.91 | -1.08 | -1.14 | -1.17 | -1.19 | -1.24 | -1.22 | -1.32 | -0.99 | -0.87 | -0.89 | -0.88 | -1.33 |
EPS (Diluted) | -0.69 | -0.61 | -0.52 | -0.49 | -0.51 | -0.75 | -0.91 | -1.08 | -1.14 | -1.17 | -1.19 | -1.24 | -1.22 | -1.32 | -0.99 | -0.87 | -0.9 | -0.89 | -1.34 |
EBITDA | -11.4M | -9.37M | -7.26M | -5.68M | -4.47M | -5.12M | -5.78M | -6.35M | -6.82M | -6.84M | -6.96M | -7.27M | -7.06M | -7.19M | -5.32M | -4.03M | -3.5M | -2.34M | -3.82M |
EBIT | -7.59M | -9.33M | -7.23M | -5.68M | -4.61M | -5.26M | -5.93M | -6.49M | -6.93M | -6.95M | -7.08M | -7.38M | -7.3M | -7.45M | -7.1M | -5.81M | -5.16M | -3.97M | -3.93M |
Depreciation & Amortization | -7.76K | 7.31K | 23.25K | 62.9K | 141.59K | 163.78K | 172.57K | 170.19K | 138.23K | 134.76K | 146.64K | 146.91K | 145.08K | 148.28K | 148.49K | 138.87K | 130.6K | 121.7K | 113.17K |